Even if you were right (which I do NOT concede) the cost versus the benefit right now doesn't make any sense to me. The money it would take to qualify and change would be MUCH better spent in the lab right now and and in solidifying relationships in the industry. Might just be me, though.
Of course, I'm an idiot. What the H&LL was I saying?
That depends, do you know what is involved in doing so? What is the advantage? How long does it take? This has been discussed, and my question is that for now, does it matter? Sure we'd get a temporary boost, but is slow sustainable growth better? Patience will be rewarded
I would much rather point to a simple step up the NASDAQ level which is inexpensive and allows for trading in both the pre and the after markets, The N\YSE listing is miles away and the criteria for listing is way above what this company can provide for sometime. When this stock passes the $1.00 level and perhaps the 1.10 to 1.20 level they will pursue a decent Nasdaq listing and get us out of this den of inequity. I say that because we don't want to take a step up and then quickly fall below a buck and have to go thru that exercise of filing for more time, etc.